ResearcherUniversity of KansasNo recent work listed
Junsheng Fu
Matched on ORCID iD 0000-0002-4197-2645; OpenAlex author ID A5101765349. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 4, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 7
2011: 1 paper · 2012: 2 papers · 2013: 2 papers · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: 1 paper
Papers 7
- Corrigendum to 'GANT-61 inhibits pancreatic cancer stem cell growth in vitro and in NOD/SCID/IL2R gamma null mice xenograft' [Canc. Lett. 330 (2013) 22-32]. Co-author DOI 10.1016/j.canlet.2021.07.028↗
- Triacetyl resveratrol upregulates miRNA‑200 and suppresses the Shh pathway in pancreatic cancer: A potential therapeutic agent. Co-author DOI 10.3892/ijo.2019.4700↗
- Sulforaphane regulates self-renewal of pancreatic cancer stem cells through the modulation of Sonic hedgehog-GLI pathway. First author DOI 10.1007/s11010-012-1493-6↗
- GANT-61 inhibits pancreatic cancer stem cell growth in vitro and in NOD/SCID/IL2R gamma null mice xenograft. Co-author DOI 10.1016/j.canlet.2012.11.018↗
- Inhibition of sonic hedgehog pathway and pluripotency maintaining factors regulate human pancreatic cancer stem cell characteristics. First author DOI 10.1002/ijc.26323↗
- Sonic hedgehog signaling inhibition provides opportunities for targeted therapy by sulforaphane in regulating pancreatic cancer stem cell self-renewal. First author DOI 10.1371/journal.pone.0046083↗
- Hedgehog signaling antagonist GDC-0449 (Vismodegib) inhibits pancreatic cancer stem cell characteristics: molecular mechanisms. First author DOI 10.1371/journal.pone.0027306↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Rakesh K. Srivastava · 7 shared papers, 2011–2021 · strength 0.47
- Paper Corrigendum to 'GANT-61 inhibits pancreatic cancer stem cell growth in vitro and in NOD/SCID/IL2R gamma null mice xenog… DOI 10.1016/j.canlet.2021.07.028↗
- Paper Triacetyl resveratrol upregulates miRNA‑200 and suppresses the Shh pathway in pancreatic cancer: A potential therapeuti… DOI 10.3892/ijo.2019.4700↗
- Paper Sulforaphane regulates self-renewal of pancreatic cancer stem cells through the modulation of Sonic hedgehog-GLI pathwa… DOI 10.1007/s11010-012-1493-6↗
- Sharmila Shankar · 7 shared papers, 2011–2021 · strength 0.47
- Paper Corrigendum to 'GANT-61 inhibits pancreatic cancer stem cell growth in vitro and in NOD/SCID/IL2R gamma null mice xenog… DOI 10.1016/j.canlet.2021.07.028↗
- Paper Triacetyl resveratrol upregulates miRNA‑200 and suppresses the Shh pathway in pancreatic cancer: A potential therapeuti… DOI 10.3892/ijo.2019.4700↗
- Paper Sulforaphane regulates self-renewal of pancreatic cancer stem cells through the modulation of Sonic hedgehog-GLI pathwa… DOI 10.1007/s11010-012-1493-6↗
- Mariana Rodova · 4 shared papers, 2012–2021 · strength 0.26
- Paper Corrigendum to 'GANT-61 inhibits pancreatic cancer stem cell growth in vitro and in NOD/SCID/IL2R gamma null mice xenog… DOI 10.1016/j.canlet.2021.07.028↗
- Paper GANT-61 inhibits pancreatic cancer stem cell growth in vitro and in NOD/SCID/IL2R gamma null mice xenograft. DOI 10.1016/j.canlet.2012.11.018↗
- Paper Sonic hedgehog signaling inhibition provides opportunities for targeted therapy by sulforaphane in regulating pancreati… DOI 10.1371/journal.pone.0046083↗
- Sanjit Kumer Roy · 2 shared papers, 2013–2021 · strength 0.19
- Paper Corrigendum to 'GANT-61 inhibits pancreatic cancer stem cell growth in vitro and in NOD/SCID/IL2R gamma null mice xenog… DOI 10.1016/j.canlet.2021.07.028↗
- Paper GANT-61 inhibits pancreatic cancer stem cell growth in vitro and in NOD/SCID/IL2R gamma null mice xenograft. DOI 10.1016/j.canlet.2012.11.018↗
- Shih-Hui Li · 1 shared paper, 2013 · strength 0.05
- Brahma Nand Singh · 1 shared paper, 2011 · strength 0.04
- Su‐Ni Tang · 1 shared paper, 2012 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.